121 related articles for article (PubMed ID: 11926185)
1. Enhanced clearance of leukemic lymphocytes in B-cell chronic lymphocytic leukemia with etodolac.
Nardella FA; LeFevre JA
Blood; 2002 Apr; 99(7):2625-6. PubMed ID: 11926185
[No Abstract] [Full Text] [Related]
2. Non-steroidal anti-inflammatory drug therapy for chronic lymphocytic leukemia.
Yasui H; Hideshima T; Anderson KC
Leuk Lymphoma; 2006 Dec; 47(12):2445-6. PubMed ID: 17169789
[No Abstract] [Full Text] [Related]
3. SDX-308 and SDX-101, non-steroidal anti-inflammatory drugs, as therapeutic candidates for treating hematologic malignancies including myeloma.
Lentzsch S; Elliott G; Roodman GD
Arch Pharm (Weinheim); 2007 Oct; 340(10):511-6. PubMed ID: 17849446
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells.
Robak P; Linke A; Cebula B; Robak T; Smolewski P
Leuk Lymphoma; 2006 Dec; 47(12):2625-34. PubMed ID: 17169808
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine A in chronic lymphocytic leukemia: dual anti-leukemic and immunosuppressive role?
Wright SJ; Keating MJ
Leuk Lymphoma; 1995 Dec; 20(1-2):131-6. PubMed ID: 8750634
[TBL] [Abstract][Full Text] [Related]
6. Morphology, atypical chronic lymphocytic leukaemia and prognostic features affecting choice of therapy.
Catovsky D
Haematologica; 1999 Jun; 84 Suppl EHA-4():92-3. PubMed ID: 10907480
[No Abstract] [Full Text] [Related]
7. Head and neck manifestations of B-cell chronic lymphocytic leukemia.
Cohen-Kerem R; Quitt M; Greenberg E; Braverman I
Otolaryngol Head Neck Surg; 2000 Dec; 123(6):784-5. PubMed ID: 11112980
[No Abstract] [Full Text] [Related]
8. Chronic lymphocytic leukemia: an historical perspective.
Gribben JG
Hematology Am Soc Hematol Educ Program; 2008; ():443. PubMed ID: 19074123
[No Abstract] [Full Text] [Related]
9. Loxoribine induces chronic lymphocytic leukemia B cells to traverse the cell cycle.
Goodman MG; Wormsley SB; Spinosa JC; Piro LD
Blood; 1994 Nov; 84(10):3457-64. PubMed ID: 7949100
[TBL] [Abstract][Full Text] [Related]
10. R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells.
Lindhagen E; Nissle S; Leoni L; Elliott G; Chao Q; Larsson R; Aleskog A
Cancer Chemother Pharmacol; 2007 Sep; 60(4):545-53. PubMed ID: 17186240
[TBL] [Abstract][Full Text] [Related]
11. Clinical performance of etodolac in patients with osteoarthritis and rheumatoid arthritis.
Veys EM
Eur J Rheumatol Inflamm; 1994; 14(1):23-7. PubMed ID: 7744125
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of chronic lymphocytic leukemia in relation to clinico- morphological characteristics of the disease].
Tumakov VA; Abdulkadyrov KM; Rugal' VI; Karpenkov MV; Ved' VV; Brodovskiĭ AF
Klin Med (Mosk); 1991 Jan; 69(1):94-7. PubMed ID: 2023411
[TBL] [Abstract][Full Text] [Related]
13. Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression.
Criado I; Muñoz-Criado S; Rodríguez-Caballero A; Nieto WG; Romero A; Fernández-Navarro P; Alcoceba M; Contreras T; González M; Orfao A; Almeida J;
Haematologica; 2017 Jul; 102(7):1238-1246. PubMed ID: 28385786
[TBL] [Abstract][Full Text] [Related]
14. [What effects has the presence of prolymphocytes on prognosis and therapy of CLL? ].
Hallek M
Dtsch Med Wochenschr; 2002 Mar; 127(9):464. PubMed ID: 11870564
[No Abstract] [Full Text] [Related]
15. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J
Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837
[TBL] [Abstract][Full Text] [Related]
16. Detection of CD5 in B-cell chronic lymphoproliferative diseases by flow cytometry: a strong expression in B-cell chronic lymphocytic leukemia.
Cavalcanti Júnior GB; Sales VS; Cavalcanti e Silva DG; Lopes MC; Paiva Ade S; da Fonseca HE; do Nascimento Júniors FF; Fernandes MZ
Acta Cir Bras; 2005; 20 Suppl 1():101-7. PubMed ID: 16186976
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
18. [Transformation of chronic lymphocytic leukemia to myelodysplastic syndrome: case presentation and review of the literature].
Telek B; Pfliegler G; Reményi G; Méhes L; Batár P; Udvardy M
Orv Hetil; 2009 Apr; 150(15):689-92. PubMed ID: 19362917
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia with low lymphocyte count.
Batata A; Shen B
Cancer; 1993 May; 71(9):2732-8. PubMed ID: 7682147
[TBL] [Abstract][Full Text] [Related]
20. Clinical use of etodolac for the treatment of lumbar disc herniation.
Hatori M; Kokubun S
Curr Med Res Opin; 1999; 15(3):193-201. PubMed ID: 10621926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
